Is marksans Pharma a good buy?
1. Is Marksans Pharma Ltd a good quality company? Past 10 year’s financial track record analysis by Moneyworks4me indicates that Marksans Pharma Ltd is a average quality company.
What is future of Marksans Pharma share?
Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 86 in its research report dated February 16, 2022.
Will marksans increase share price?
Marksans Pharma Ltd . quote is equal to 44.850 INR at 2022-06-14. Based on our forecasts, a long-term increase is expected, the “Marksans Pharma Ltd” stock price prognosis for 2027-06-04 is 134.487 INR. With a 5-year investment, the revenue is expected to be around +199.86%.
Is marksans Pharma Debt Free?
What Is Marksans Pharma’s Net Debt? The image below, which you can click on for greater detail, shows that at March 2019 Marksans Pharma had debt of ₹1.31b, up from ₹1.17b in one year. However, because it has a cash reserve of ₹335.4m, its net debt is less, at about ₹972.8m.
What is news about marksans Pharma?
Marksans Pharma Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on May 30, 2022, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended March 31, 2022.
What does marksans Pharma do?
Marksans Pharma Ltd. is an Indian pharmaceutical company having a global footprint. Our strengths lie in research, manufacturing and marketing of finished dosage pharmaceutical formulations.
Is marksans Pharma good for long term investment?
Marksans Pharma was able to grow its EPS at 54% per year over three years, sending the share price higher. This EPS growth is higher than the 22% average annual increase in the share price. So it seems investors have become more cautious about the company, over time.
Who is the owner of Marksans Pharma?
Mark B. SaldanhaMarksans Pharma / CEO
What is the target of Marksans Pharma?
| Date | Stock | Target |
|---|---|---|
| 14 Oct 2021 | Marksans Pharma Ltd. | 87.00 |
Who owns marksans Pharma?
Mark Saldanha
Mr. Mark Saldanha is the Chairman and Managing Director of Marksans. He set out with a vision to create a global pharmaceutical company.
Is Marksans Pharma an Indian company?
What are the products of Marksans Pharma?
USA
- Ibuprofen 200mg (Brown & white)
- Ibuprofen 200mg sogt gel Capsules.
- Ibuprofen Rx 400, 600 & 800mg Tablets.
- Metformin HCl 500, 850 & 1000mg Tablets.
- Metformin HCl ER Tablets.
- Metformin HCl ER Tablets.